April 23, 2026
The Path Forward: TAG’s Vision for HIV, TB, and Hepatitis C
TAG’s leadership and staff broke down the latest in HIV, TB, and hepatitis C research and advocacy. See where the work stands and where it’s headed.
April 16, 2026
Research Toward a Cure Trials
Ending HIV requires sustained research. TAG’s April 2026 cure trials update tracks clinical studies worldwide, helping advocates, researchers, and communities follow progress toward a cure.
April 3, 2026
Near Point-of-Care TB Tests: What Communities Need to Know and Advocate for in Global Fund Grant Cycle 8
TB testing is getting faster, cheaper, and more accessible and advocates have a critical window to act. Treatment Action Group’s new factsheet breaks down WHO-recommended near point-of-care TB tests and shows how communities can use Global Fund Grant Cycle 8 to finance their rollout. With an estimated 2.7 million people…
March 24, 2026
World Tuberculosis Day 2026
On World TB Day, TAG is excited to share our most recent TB vaccine materials: a new TB vax-zine, community partnership report on emerging vaccines, supply chain analysis of adjuvants that boost vaccine effectiveness, and the most recent pipeline report on TB vaccines in development.
January 20, 2026
What Could Go Right? Vital Partnerships with Communities and Civil Society for New Tuberculosis Vaccines
What Could Go Right: Vital Partnerships with Communities and Civil Society for New Tuberculosis Vaccines, written together with community partners and supported by Wellcome, explores the indispensable role of communities and civil society in preparing the way for new TB vaccines and ensuring their success once they become available.